Geneos Wealth Management’s First Trust Expanded Technology ETF XPND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.8K Sell
394
-4,498
-92% -$176K ﹤0.01% 2213
2026
Q2
$205K Sell
4,892
-172
-3% -$6.6K ﹤0.01% 982
2026
Q1
$166K Buy
5,064
+180
+4% +$6.24K ﹤0.01% 1020
2025
Q4
$176K Hold
4,884
– – ﹤0.01% 963
2025
Q3
$177K Buy
4,884
+1,656
+51% +$57K ﹤0.01% 940
2025
Q2
$109K Sell
3,228
-426
-12% -$12.8K ﹤0.01% 1218
2025
Q1
$103K Sell
3,654
-1,711
-32% -$52.3K ﹤0.01% 1154
2024
Q4
$163K Sell
5,365
-733
-12% -$22.1K 0.01% 912
2024
Q3
$175K Sell
6,098
-723
-11% -$20K 0.01% 808
2024
Q2
$192K Sell
6,821
-871
-11% -$23.1K 0.01% 712
2024
Q1
$204K Buy
+7,692
New +$195K 0.01% 699

Other funds holding XPND

Geneos Wealth Management's XPND Position: Q3 2026 in Review

Geneos Wealth Management reduced its First Trust Expanded Technology ETF (XPND) stake by 92% in Q3 2026, selling an estimated $176K and leaving 394 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2213.

Geneos Wealth Management first reported a position in XPND in Q1 2024 and has held it in 11 quarters since. The position peaked at $205K in Q2 2026. 26 funds tracked by Wall St. Rank hold XPND as of Q3 2026.

  • Geneos Wealth Management held 394 shares of First Trust Expanded Technology ETF worth $15.8K as of Q3 2026.
  • Geneos Wealth Management sold 4,498 First Trust Expanded Technology ETF shares in Q3 2026, an estimated $176K.
  • First Trust Expanded Technology ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2213 holding.
  • Geneos Wealth Management first reported a position in First Trust Expanded Technology ETF in Q1 2024 and has held it in 11 quarters since.
  • Geneos Wealth Management's First Trust Expanded Technology ETF position peaked at $205K in Q2 2026.
  • 26 funds tracked by Wall St. Rank held First Trust Expanded Technology ETF as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.